Future research should prioritise discovery and validation of pathways that:○ find aggressive cancers that are currently being missed;○ further reduce harms (unnecessary biopsies and detection of clinically insignificant disease) in men who undergo PSA testing through informed choice; and○ allow for better risk stratification of men who undergo PSA testing through informed choice. This evidence concerns the gene KLK3 and cancer.